Internal Medicine, Cardiovascular Disease · Fresno, CA
NPI
1891782256
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
1313 E Herndon Ave, Suite 203
Fresno, CA, 93720
Phone (559) 439-6808
Groups this clinician bills Medicare through
Medicare paid, 2024
$158K
2,416 services
Medicare patients, 2024
733
Average age 78
Drug cost, 2024
$1.0M
2,765 prescriptions
Company payments, 2024
$30.64
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John G Telles was code 99214 (office e&m - established), 521 times for 465 patients. In total John G Telles billed 2,416 services in 55 codes, and Medicare paid $158K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 521 | 465 | $79.35 | $41K |
| 93040 Electrocardiogram | Office | 442 | 377 | $8.50 | $3,757 |
| 99213 Office E&M - Established | Office | 212 | 186 | $54.03 | $11K |
| 93288 External Electrocardiographic Monitoring | Office | 140 | 114 | $35.81 | $5,014 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 140 | 35 | $8.93 | $1,250 |
| 93306 Echocardiography (TTE/TEE) | Office | 104 | 104 | $139.70 | $15K |
| 93010 Electrocardiogram | Facility | 70 | 64 | $5.01 | $351 |
| 93000 Electrocardiogram | Office | 69 | 60 | $8.84 | $610 |
| 93306 Echocardiography (TTE/TEE) | Facility | 61 | 61 | $49.60 | $3,026 |
| 93289 External Electrocardiographic Monitoring | Office | 60 | 44 | $49.66 | $2,980 |
| 93351 Echocardiography (TTE/TEE) | Office | 49 | 49 | $166.97 | $8,182 |
| 93320 Echocardiography (TTE/TEE) | Office | 49 | 49 | $36.54 | $1,791 |
| 93325 Echocardiography (TTE/TEE) | Office | 49 | 49 | $16.06 | $787 |
| 93015 Electrocardiogram | Office | 38 | 38 | $55.48 | $2,108 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 38 | 19 | $35.99 | $1,367 |
By year: 2022 $631K for 7,972 services; 2023 $478K for 6,746 services; 2024 $158K for 2,416 services.
Medicare prescription drug claims, 2024
In 2024, the drug John G Telles prescribed most often to Medicare patients was Eliquis (Apixaban), with 526 prescriptions and refills. In total John G Telles wrote 2,765 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 526 | 1,076 | 165 | $615K |
| Metoprolol Succinate Generic | 314 | 908 | 138 | $5,350 |
| Propafenone Hcl Generic | 235 | 677 | 96 | $17K |
| Losartan Potassium Generic | 156 | 438 | 60 | $1,839 |
| Furosemide Generic | 143 | 400 | 68 | $858 |
| Carvedilol Generic | 113 | 330 | 48 | $1,004 |
| Xarelto Rivaroxaban | 110 | 302 | 44 | $162K |
| Spironolactone Generic | 105 | 285 | 42 | $1,037 |
| Entresto Sacubitril/Valsartan | 85 | 223 | 31 | $126K |
| Atorvastatin Calcium Generic | 82 | 243 | 37 | $952 |
| Clopidogrel Clopidogrel Bisulfate | 79 | 232 | 35 | $1,027 |
| Potassium Chloride Generic | 74 | 214 | 39 | $2,821 |
| Amlodipine Besylate Generic | 73 | 217 | 28 | $407 |
| Amiodarone Hcl Generic | 70 | 190 | 33 | $1,776 |
| Lisinopril Generic | 58 | 173 | 28 | $448 |
Brand drugs: 849 claims; generic drugs: 1,916 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John G Telles $30.64 ($30.64 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $30.64.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 2 | $30.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.